about
Generation and biological activities of oxidized phospholipidsPhosphorylcholine-dependent cross-reactivity between dental plaque bacteria and oxidized low-density lipoproteins.Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early lifeUnique antibody responses to malondialdehyde-acetaldehyde (MAA)-protein adducts predict coronary artery diseaseMalondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosisRecognition of Porphyromonas gingivalis gingipain epitopes by natural IgM binding to malondialdehyde modified low-density lipoprotein.The macrophage foam cell as a target for therapeutic intervention.Oxidized low-density lipoprotein is present in astrocytes surrounding cerebral infarcts and stimulates astrocyte interleukin-6 secretionRegulation of age-related macular degeneration-like pathology by complement factor H.Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals.Immune response to lipoproteins in atherosclerosis.Inflammation in atherosclerosis and other conditions: a response to danger.Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatoryIL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.Oxidative stress, innate immunity, and age-related macular degenerationOxidation-specific epitopes are important targets of innate immunity.Antigen-induced immunomodulation in the pathogenesis of atherosclerosis.A Liposome-Based Approach to the Integrated Multi-Component Antigen Microarrays.Cross-reactive saliva IgA antibodies to oxidized LDL and periodontal pathogens in humans.The Human Thymus Is Enriched for Autoreactive B Cells.Splenic immunity and atherosclerosis: a glimpse into a novel paradigm?Lipid levels including oxidized LDL in women with history of preeclampsia.Oxidized LDL accumulation in experimental renal ischemia reperfusion injury model.Oxidized low density lipoprotein exposure alters the transcriptional response of macrophages to inflammatory stimulus.B-1 cell immunoglobulin directed against oxidation-specific epitopes.Plasma IgA antibody levels to malondialdehyde acetaldehyde-adducts are associated with inflammatory mediators, obesity and type 2 diabetes.Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E.Assessment of atherosclerotic risk factors and endothelial function in children and young adults with pediatric-onset systemic lupus erythematosus.Persistent high levels of IgM antiphospholipid antibodies in a patient with recurrent pregnancy losses and rheumatoid arthritis.Human monoclonal Fab and human plasma antibodies to carbamyl-epitopes cross-react with malondialdehyde-adducts
P2860
Q28389691-F0E0CF71-C1B9-447E-AE9B-50F58DB5C462Q33551868-64ADBEA6-257B-4524-A1AD-97D2BE4757A7Q33735189-AF6BC8EE-6613-4F1D-AE0C-57EE77D629FCQ34166358-03F568F1-7D53-48F6-92DE-F73239E5B4ACQ34188667-2BFE9D86-E150-472A-9569-46D7C3045BCAQ34230397-A04AD0FF-8EB1-45B0-A153-57D37F67FEAFQ34986351-187E8895-2BA7-4B6D-934E-E9325586BD2BQ35097354-3C7BE7AA-8AD7-4178-AA1C-B7188118F463Q35740328-9DAD6BF4-37C6-4DE7-9D4B-494B42F5F55EQ35965242-29A32D94-3AED-471E-8C5E-5EB16B7BDC16Q36203882-F19B97B7-6A0E-45C8-8752-5004824B5514Q36207241-774C2D7C-058E-4DB0-ACF6-44ACC9F6745BQ36399652-16EE63C6-4FCE-4576-93F9-C23B3F9EA595Q36849075-00820892-1281-4014-AA51-0610310A9D4CQ36940296-834FE6D8-4B42-4770-B231-80967752A823Q37138021-A8A8775F-DAE7-4229-9A58-28986A8B767CQ37190468-658775D2-B470-4F91-B259-96C574E8A452Q37200851-BEDFA4E6-B1E3-4F6B-9802-5619CDEA40DBQ38761773-E99EADD1-3439-445B-8D0F-6C2D81D238E2Q39711277-DE13D75C-4FEE-4F2C-AFEC-67FB22F6F964Q39737712-E04B3AA7-6C03-4DBB-9C68-07FB2C48D2D1Q39903413-FA08F0DF-A46E-4932-95B0-0C2A9BD67098Q40213688-40D98171-B062-4B0E-AB74-EFAC0441A7D8Q40778017-632BAAC4-89F4-4A27-B63D-35BF03A2AA2DQ41857156-B4B8D018-B976-4714-B036-7E3DCC756816Q43523503-8EBB4385-0500-4F78-A5D4-C7623A934567Q44053804-66E486F1-857A-4D51-8ABF-09DBFF73BD51Q44929993-FCA2DECE-32CF-4660-ABE1-F4D22B1F0801Q50866340-84F093C9-3848-46B1-8EC0-427E83811FBDQ56891373-99186F71-4211-4EA6-996A-95C1FD53B504
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Immunological responses to oxidized LDL.
@ast
Immunological responses to oxidized LDL.
@en
Immunological responses to oxidized LDL.
@nl
type
label
Immunological responses to oxidized LDL.
@ast
Immunological responses to oxidized LDL.
@en
Immunological responses to oxidized LDL.
@nl
prefLabel
Immunological responses to oxidized LDL.
@ast
Immunological responses to oxidized LDL.
@en
Immunological responses to oxidized LDL.
@nl
P2093
P1476
Immunological responses to oxidized LDL
@en
P2093
P304
P356
10.1016/S0891-5849(00)00333-6
P577
2000-06-01T00:00:00Z